What Did You Buy Today?

[vbin]

(08-19-2019, 10:25 AM)fenders53 Wrote: My thoughts are this is not a slam dunk.  #2 is my biggest concern.  Replacing a blockbuster drug is not automatic and that is why #3 occurred.  ABBV inherited their aristocrat status from ABT so their inclusion i the club is meaningless to me.  The political pharma hate-fest is just getting started with election coming.   

Personally I want a position but not convinced it couldn't go lower.  I want to enter as cheap as possible.   I am selling puts and so far they expire worthless.  I'll collect the premiums and keep doing it until I am forced in as low as possible.  Just in case it turns out like PFE.  I rode that dead horse for 15+ years waiting for a recovery.  IMO ABBV is not a no brainer all will be surely well in a couple years proposition, though that is how DGI folks seem to regard it.       

So I'm cautiously optimist or I wouldn't be trying to enter yet.  I was amazed folks were interested a year ago.  It seemed obvious to me it was a gamble. It looked like a yield trap to me. It looks better from here.

Selling puts is how I also got it this time. Had sold some put a day before ex-div so avg is approx ~$68 for me.

I agree with u that high possibility of further pullback and I am interested to add more below $60. You raised the same concern over HUMIRA but no one seems to justify that why it will be fine in couple of years. To me that's a big gray area post 2023 where I am trying to get clarity.